cll
Showing NaN - NaN of 2
Chronic Lymphocytic Leukemia, CLL, SLL Trial in United States (TP-0903, TP-0903 and ibrutinib combination therapy)
Terminated
- Chronic Lymphocytic Leukemia
- +3 more
- TP-0903
- TP-0903 and ibrutinib combination therapy
-
Phoenix, Arizona
- +5 more
Apr 4, 2022